Anorexia nervosa (AN) is a group biologically-based serious 11 mental illness of growing clinical and social impact due to its 12 increasing prevalence in general population, and to its long and 13 severe course, associated to high rates of chronicity, mortality and 14 relapse [1] [2] [3] [4] . 15
Current follow-up studies on AN are limited in number, 16 hampered by dropout rates, sample width, and heterogeneity, 17
and also affected by a lack of consistence about definitions of 18 recovery, remission and relapse [5] . According to literature studies 19 published in the last ten years, AN course and outcome show a 20 huge heterogeneity [6] . Remission rates appeared to be related 21 with follow-up duration, with global EDs remission rates around 22 48.7% at 2.5 years follow-up [7] . Nevertheless, it is frequent the 23 diagnostic crossover, and there is a heavy influence of complicating 24 factors on outcome [8] .
25 The AN shows the highest time to obtain remission among other 26 eating disorders (EDs) [7, 8] . Remission rates for AN are 37.1% after 27 2.5 years, with partial remission but favorable outcome in 68.6% of 28 patients [7] , and from 52.1% to 53.9% after 6 years [9] . These results 29 are maintained at 12 years follow-up [10] . Binge-purging subtype of 30 AN showed lower recovery rates than restricter subtype [7] . Studies 31 with more restrictive criteria, that consider remission as stable 32 absence of any eating symptom and maintenance of normal BMI for 33 almost 3 years, showed considerably lower remission rates, around 34 15% in AN at 12 years follow-up [5] . Transitions from AN to full 35 criteria BN are less frequent (cumulative probability across studies 36 around 2:1) and crossover from BN to AN are unlikely (cumulative 37 probability around 13:1) [8] .
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In addition to the heterogeneity of the findings, a major limit of 39 follow-up studies is that they are mostly based on objective 40 symptoms and body weight [11] [12] [13] 
